Literature DB >> 35088073

Management of eosinophilic esophagitis associated food impaction in Europe and the United States.

Philipp Schreiner1, Ekaterina Safroneeva2, Alain Schoepfer3, Thomas Greuter3, Luc Biedermann1, Christoph Schlag1, Joachim Labenz4, Marcus K H Auth5, Albert J Bredenoord6, Joy W Chang7, Peter A Bonis8, Marc E Rothenberg9, Margaret H Collins10, Ikuo Hirano11, Sandeep K Gupta12, David A Katzka13, Evan S Dellon14, Alex Straumann1, Glenn T Furuta15, Nirmala Gonsalves11.   

Abstract

Eosinophilic esophagitis (EoE) is the most common cause of esophageal food impaction (EFI). Approaches to management of EFI due to EoE have not been well characterized. We conducted a web-based survey to understand approaches to management of EFI due to EoE among endoscopists. Questions focused on management of patients from presentation to post-endoscopy follow-up. The survey was administered to a list of eligible candidates provided by societies of gastroenterology. A total of 308 endoscopists completed the questionnaire. The majority (83%) practiced in Europe and treated adults (78%). Most agreed patients should be advised to seek emergency care (66%) within 1 to 2 hours (41% agreement). There was agreement that medications to induce vomiting should be avoided (84%) and that blood tests or imaging studies were usually not required before endoscopy. By contrast, there was more variability in the type of sedation recommended and the need for endotracheal intubation, especially when comparing more experienced with less experienced EoE-endoscopists. Overall, fewer than half (43%) respondents recommended obtaining esophageal biopsies during the initial endoscopy. However, there were significant differences in the proportion who recommended biopsies based on level of EoE-experience (25, 52, 77%, P < 0.001; less vs. moderate vs. very experienced) and comparing pediatric and adult endoscopists (32, vs. 79%, P < 0.001; adult vs. pediatric). There exists heterogeneity among endoscopists in recommendations to manage EFI in patients with EoE. These findings support development of clinical guidelines and new studies to clarify the rationale for best practices. Key summary: Established knowledge-The optimal management of patients with esophageal food impaction due to eosinophilic esophagitis from presentation at the emergency department to postendoscopy care is unclear. New findings-Considerable recommendation variation exists in the management of EFI in patients with EoE. Our findings provide a rationale for the creation of consensus practice guidelines and further study into best practices.
© The Author(s) 2022. Published by Oxford University Press on behalf of International Society for Diseases of the Esophagus. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  eosinophilic esophagitis; esophageal food impaction; esophagus

Mesh:

Year:  2022        PMID: 35088073     DOI: 10.1093/dote/doac003

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   2.822


  1 in total

1.  Accurate and timely diagnosis of Eosinophilic Esophagitis improves over time in Europe. An analysis of the EoE CONNECT Registry.

Authors:  Pilar Navarro; Emilio J Laserna-Mendieta; Sergio Casabona; Edoardo Savarino; María Teresa Pérez-Fernández; Matteo Ghisa; Isabel Pérez-Martínez; Danila Guagnozzi; Antonia Perelló; Antonio Guardiola-Arévalo; Francesca Racca; Elena Betoré; Leonardo Blas-Jhon; Anne Lund Krarup; Verónica Martín-Domínguez; Daria Maniero; Adolfo Suárez; Ronald Llerena-Castro; Luisa de la Peña-Negro; Alicia Granja Navacerrada; Gaia Pellegatta; Javier Alcedo; Lonore de Hurtado Mendoza-Guena; Sara Feo-Ortega; Jesús Barrio; Carolina Gutiérrez-Junquera; Sonia Fernández-Fernández; Susana De la Riva; Juan E Navés; Silvia Carrión; Constanza Ciriza de Los Ríos; Natalia García-Morales; Juan Armando Rodríguez-Oballe; Raffaela Dainese; Alba Rodríguez-Sánchez; María Lluisa Masiques-Mas; María Teresa Palomeque; Cecilio Santander; Sonsoles Tamarit-Sebastián; Ángel Arias; Alfredo J Lucendo
Journal:  United European Gastroenterol J       Date:  2022-05-16       Impact factor: 6.866

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.